Tuanyuan Shi

Title: Tuanyuan Shi: Innovator in Vaccine Development

Introduction

Tuanyuan Shi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of vaccine development, particularly through his innovative use of coccidian as a live vaccine vector. His work has the potential to enhance immune responses in organisms, paving the way for advancements in immunology.

Latest Patents

Tuanyuan Shi holds a patent for the "Use of coccidian." This invention provides a novel application of coccidian, specifically as a live vaccine vector. The patent details a live vaccine that utilizes transgenic coccidian capable of expressing exogenous proteins or stably transfected coccidian containing expression vectors. This innovative approach can induce protective humoral and cellular immune responses, including mucosal immune responses, while generating memory responses. The coccidian vector live vaccine is noted for its stable effects and high biological safety, without causing immune tolerance.

Career Highlights

Throughout his career, Tuanyuan Shi has worked with notable institutions, including China Agricultural University. His research has focused on the intersection of coccidian biology and vaccine technology, contributing to the development of safer and more effective vaccines.

Collaborations

Tuanyuan Shi has collaborated with esteemed colleagues such as Xun Suo and Xiaojia Wang. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in vaccine development.

Conclusion

Tuanyuan Shi's contributions to the field of vaccine development through his innovative use of coccidian as a live vaccine vector highlight his role as a leading inventor. His work not only advances scientific knowledge but also has the potential to improve public health outcomes.